Clinical Trial Update: A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating lung clearance after hypertonic saline delivery using the tPAD device in cystic fibrosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University of Pittsburgh | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED